{"id":"W4385456000","doi":"10.3899/jrheum.2023-0625","title":"Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1","year":2023,"lang":"en","type":"letter","venue":"The Journal of Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University; Memorial University of Newfoundland; University of Saskatchewan; Canadian Rheumatology Association; University of British Columbia; McMaster University; Toronto General Hospital; Western University; Canadian Arthritis Patient Alliance; University of Toronto; University Health Network; University of Calgary; Mount Sinai Hospital; University of Ottawa; Research Canada; Cochrane; Impact","funders":"Samsung; Swedish Orphan Biovitrum; Celltrion; Eli Lilly and Company; Celltrion Healthcare; Biogen; Celgene; Teva Pharmaceutical Industries; Cumming School of Medicine, University of Calgary; Mylan; University of Calgary; Gilead Sciences; Sanofi; Amgen; Pfizer; Canadian Rheumatology Association","keywords":"Medicine; Rheumatoid arthritis; Rheumatology; Internal medicine; Association (psychology); Physical therapy; Arthritis; Family medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005416707,0.001076362,0.001907344,0.006283852,0.001362827,0.003580566,0.003275583,0.004294392,0.04892419],"category_scores_gemma":[0.02845974,0.0006729666,0.001991145,0.005603435,0.0009875684,0.002209685,0.001844264,0.006632248,0.02859541],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00968206,"about_ca_system_score_gemma":0.04152935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2455833,"about_ca_topic_score_gemma":0.3997103,"domain_scores_codex":[0.99136,0.001229216,0.001113296,0.0003186511,0.005262612,0.0007161976],"domain_scores_gemma":[0.9702671,0.002947061,0.001649025,0.0005364905,0.0227842,0.001816125],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001542926,0.00001282786,0.000169233,0.001041047,0.00001489221,0.00004797042,0.00003830836,0.00003434299,0.00005547372,0.0008907313,0.9362857,0.06139403],"study_design_scores_gemma":[0.00003721154,0.000007460593,0.0006660811,0.003181405,0.00003895332,0.0002101944,0.00003078658,0.00002227313,0.00002285641,0.0004629031,0.9953077,0.00001206479],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.0009674422,0.5017592,0.005482672,0.1925692,0.03768956,0.001765329,0.03625126,0.001352479,0.2221628],"genre_scores_gemma":[0.01018107,0.6029172,0.03865533,0.09230288,0.01794636,0.002163632,0.1047222,0.0009118417,0.1301995],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.9903179,"threshold_uncertainty_score":0.4883077,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03172431124231478,"score_gpt":0.3063497794686217,"score_spread":0.274625468226307,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}